Literature DB >> 25657892

Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS).

Kenneth Blum1, Marlene Oscar-Berman2, Rajendra D Badgaiyan3, Khurshid A Khurshid4, Mark S Gold4.   

Abstract

It is well-known that sleep has a vital function especially as it relates to prevention of substance-related disorders as discussed in the DSM-V. We are cognizant that certain dopaminergic gene polymorphisms have been associated with various sleep disorders. The importance of "normal dopamine homeostasis" is tantamount for quality of life especially for the recovering addict. Since it is now know that sleep per se has been linked with metabolic clearance of neurotoxins in the brain, it is parsonomiuos to encourage continued research in sleep science, which should ultimately result in attenuation of sleep deprivation especially associated with substance related disorders.

Entities:  

Keywords:  Reward Deficiency Syndrome (RDS); dopaminergic system; metabolic clearance of neurotoxins; neurogenetics; sleep

Year:  2014        PMID: 25657892      PMCID: PMC4314958          DOI: 10.4172/2167-0277.1000e126

Source DB:  PubMed          Journal:  J Sleep Disord Ther        ISSN: 2167-0277


  30 in total

Review 1.  Secondary ''incidental'' REM sleep behavior disorder: do we ever think of it?

Authors:  Raffaele Manni; Pietro-Luca Ratti; Michele Terzaghi
Journal:  Sleep Med       Date:  2011-12       Impact factor: 3.492

Review 2.  Sleep disorders.

Authors:  Ulrich Voderholzer; Christian Guilleminault
Journal:  Handb Clin Neurol       Date:  2012

3.  Delayed sleep phase disorder and attention deficit and hyperactivity symptoms in a teenager.

Authors:  Khurshid A Khurshid; Aliya A Khan
Journal:  Atten Defic Hyperact Disord       Date:  2009-11-05

4.  A multistudy analysis of the effects of early cocaine abstinence on sleep.

Authors:  D Matuskey; B Pittman; E Forselius; R T Malison; P T Morgan
Journal:  Drug Alcohol Depend       Date:  2010-12-08       Impact factor: 4.492

5.  Influence of genotype on dopamine transporter availability in human striatum and sleep architecture.

Authors:  Camila Guindalini; Raquel Cristina Martins; Monica L Andersen; Sergio Tufik
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

6.  Pain depression and sleep disorders among methadone maintenance treatment patients.

Authors:  Dorit Pud; Cheryl Zlotnick; Eli Lawental
Journal:  Addict Behav       Date:  2012-06-15       Impact factor: 3.913

7.  Slow-wave sleep and ventricular size: a comparative study in schizophrenia and major depression.

Authors:  C J Lauer; J C Krieg
Journal:  Biol Psychiatry       Date:  1998-07-15       Impact factor: 13.382

8.  A longitudinal study of drinking and depression as predictors of insomnia in alcohol-dependent individuals.

Authors:  Olena Zhabenko; Amy R Krentzman; Elizabeth A R Robinson; Kirk J Brower
Journal:  Subst Use Misuse       Date:  2013-04-08       Impact factor: 2.164

9.  "They silently live in terror…" why sleep problems and night-time related quality-of-life are missed in children with a fetal alcohol spectrum disorder.

Authors:  Osman S Ipsiroglu; William H McKellin; Norma Carey; Christine Loock
Journal:  Soc Sci Med       Date:  2012-12-08       Impact factor: 4.634

Review 10.  Cocaine and sleep: early abstinence.

Authors:  Peter T Morgan; Robert T Malison
Journal:  ScientificWorldJournal       Date:  2007-11-02
View more
  3 in total

1.  Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases.

Authors:  Kenneth Blum; David Han; David Baron; Shan Kazmi; Igor Elman; Luis Llanos Gomez; Marjorie C Gondre-Lewis; Panyotis K Thanos; Eric R Braverman; Rajendra D Badgaiyan
Journal:  Curr Psychiatry Res Rev       Date:  2022-06-21

2.  Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.

Authors:  B W Downs; K Blum; D Bagchi; S Kushner; M Bagchi; J M Galvin; McG Lewis; D Siwicki; R Brewer; B Boyett; D Baron; J Giordano; R D Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2020-04-30

3.  Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake.

Authors:  Lucien L Duquette; Frank Mattiace; Kenneth Blum; Roger L Waite; Teresa Boland; Thomas McLaughlin; Kristina Dushaj; Marcelo Febo; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2016-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.